Real-world use of patiromer in patients with hyperkalaemia: A retrospective study from the Valencian Community;

Autores de IIS La Fe

• Pilar Sanchez Perez

  Autor

Participantes ajenos a IIS La Fe

• Moncho-Francés F.
• Gonzales-Candia B.
• Perez-Silvestre J.
• Sandin M.
• Garcia-Maset R.
• Pantoja J.
• Carbonell-Asins J.A.
• Gimenez-Civera E.
• De la Espriella R.
• Puchades M.J.
• Nuñez J.
• Górriz J.L.

Abstract

Abstract no disponible

Keywords

• dipeptidyl carboxypeptidase inhibitor; mineralocorticoid antagonist; patiromer; potassium; adverse event; aged; Article; chronic kidney failure; constipation; drug efficacy; drug safety; drug tolerance; drug use; drug withdrawal; female; human; hypercalcemia; hyperkalemia; kidney failure; maintenance therapy; major clinical study; male; multicenter study; nausea; observational study; potassium blood level; retrospective study; treatment duration; Valencian Community; vomiting